These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1365354)

  • 21. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
    Cain ME
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):115. PubMed ID: 16505838
    [No Abstract]   [Full Text] [Related]  

  • 22. Implantable cardioverter defibrillator therapy: ten years experience in a medical center.
    Chen TE; Wang CC; Chang SH; Yeh SJ; Wu D
    Chang Gung Med J; 2008; 31(1):81-90. PubMed ID: 18419057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inadequate therapeutic effects of implantable cardioverter/defibrillators: etiology, therapy and prevention].
    Mattke S; Dorwarth U; Müller D; Hoffmann E; Markewitz A; Kaulbach H; Schmöckel M; Steinbeck G
    Z Kardiol; 1994 May; 83(5):359-65. PubMed ID: 8053245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrical storm and implanted defibrillators.
    Davis CP
    South Med J; 2007 May; 100(5):547-8. PubMed ID: 17534103
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Implantable cardioventer defibrillator in the treatment of malignant ventricular arrhythmias and its short-term follow-up].
    Liu QM; Zhang Y; Zhou SH
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):179-80. PubMed ID: 12575357
    [No Abstract]   [Full Text] [Related]  

  • 28. [Indications for implantable automatic defibrillators].
    Leenhardt A; Coumel P; Thomas O; Leclercq JF; Slama R
    Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):61-6. PubMed ID: 7944867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and limitations of treatment of ventricular fibrillation/ventricular tachycardia storm by subcutaneous implantable cardioverter defibrillator.
    Nagra B; Awan MU; Miriyala V; Kantharia BK
    Int J Cardiol; 2016 Nov; 222():978-979. PubMed ID: 27529389
    [No Abstract]   [Full Text] [Related]  

  • 30. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
    Rahimtoola SH
    Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
    [No Abstract]   [Full Text] [Related]  

  • 33. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 34. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tachycardia pacing for ventricular tachycardia: good even after being bad.
    Arias MA; Puchol A; Castellanos E; Rodríguez-Padial L
    Europace; 2007 Nov; 9(11):1062-3. PubMed ID: 17666444
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
    Prystowsky EN
    Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment approaches for patients with sustained VT/VF.
    Mitchell LB; Roy D
    Can J Cardiol; 2000 Jun; 16 Suppl C():23C-5C. PubMed ID: 10887274
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry.
    Di Biase L; Gasparini M; Lunati M; Santini M; Landolina M; Boriani G; Curnis A; Bocchiardo M; Vincenti A; Denaro A; Valsecchi S; Natale A; Padeletti L;
    J Am Coll Cardiol; 2008 Oct; 52(18):1442-9. PubMed ID: 19017510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators:
    Sweeney MO
    Pacing Clin Electrophysiol; 2004 Sep; 27(9):1292-305. PubMed ID: 15461721
    [No Abstract]   [Full Text] [Related]  

  • 40. Temporal relationship of implantable cardioverter defibrillator discharges and environmental physical activity.
    Stoupel E; Kusniec J; Mazur A; Zabarsky R; Golovchiner G; Abramson E; Strasberg B; Battler A
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):777-81. PubMed ID: 16105003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.